Status:
UNKNOWN
Long-term Effectiveness of a Recombinant Hepatitis E Vaccine
Lead Sponsor:
Xiamen University
Collaborating Sponsors:
Dongtai Center for Disease Control and Prevention
Dongtai Hospital of Traditional Chinese Medicine
Conditions:
Hepatitis E
Eligibility:
All Genders
32-82 years
Brief Summary
This test-negative study is designed to evaluate the long-term effectiveness of hepatitis E vaccine (Hecolin®) and to explore the prevalence of rat hepatitis E in Dongtai City.
Detailed Description
In this negative test study, residual clinical serum will be collected from 13 hospitals in Dongtai, if it was from patients born between 1941-1991 from 11 towns in Dongtai, who tested positive for AL...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- From 11 townships（Anfeng、Fuan、Tangyang、Hougang、Liangduo、Qingdong、Shiyan、Shenzao、Wulie、Xuhe、Xinjie）
- ALT ≥ 2.5 ULN
- Born between 1941 and 1991
Exclusion
Key Trial Info
Start Date :
August 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
2900 Patients enrolled
Trial Details
Trial ID
NCT05976594
Start Date
August 12 2023
End Date
July 1 2025
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongtai Center for Disease Control and Prevention
Dongtai, Jiangsu, China, 224200